Quanterix Corp (QTRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth Amid Regional ...
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
Express News | Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.d., J.d. to Board of Directors
Quanterix Announces Commercialization of P-Tau 217 Test Kit
Exact Sciences, Quanterix Extend Slide After Medicare Rates
Leerink Partners Maintains Quanterix(QTRX.US) With Buy Rating
Leerink Partners Sticks to Its Buy Rating for Quanterix (QTRX)
Watching Quanterix; Traders Circulate Analyst Comments Suggesting The Preliminary CLFS Determinations For New Codes Was Just Published With Worse Than Expected Decisions For Neuro Diagnostics, The Advisory Panel Voted To Crosswalk To $130 For Tests...
Strong Week for Quanterix (NASDAQ:QTRX) Shareholders Doesn't Alleviate Pain of Three-year Loss
Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
Masoud Toloue Bought 11% More Shares In Quanterix
Express News | Jeffrey Elliott Appointed to Quanterix’s Board of Directors
Jeffrey Elliott Appointed to Quanterix's Board of Directors
Quanterix President Acquires 11% More Stock
Insider Buying: President & CEO Masoud Toloue Acquires Shares of Quanterix Corp (QTRX)
Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Doximity (DOCS) and Warby Parker (WRBY)
Quanterix Price Target Cut to $28.00/Share From $32.00 by Scotiabank
Scotiabank Keeps Their Buy Rating on Quanterix (QTRX)
Quanterix Corporation (NASDAQ:QTRX) Just Reported, And Analysts Assigned A US$22.00 Price Target
Quanterix Second Quarter 2024 Earnings: Beats Expectations